果冻传媒

InnoFluidics aims for decreasing the cancer burden by providing innovative technologies. We are building a microfluidics鈥恇ased platform for blood analysis of cancer patients. We are working towards delivering the best performing technology to the market. 

We are developing a liquid biopsy platform relying on label鈥恌ree, fast, and sensitive electrical measurements for enumeration, purification, and collection of intact CTCs (circulating tumor cells) directly from patient blood. The platform operates as a sample鈥恑n鈥恟esult鈥恛ut format: CTCs are detected, enumerated, purified, and collected in one go.